House Committee Advances User Fees With Full Slate Of Device Amendments

House Energy and Commerce Committee members added a slate of industry-favored device amendments into the FDA Reauthorization Act before sending the bill to the chamber floor, including reforms targeting device accessories, medical imaging and post-market surveillance.

Capitol House

[Editors' note: Follow progress with legislation impacting the device and diagnostics industry with the Medtech Insight's US Congress Tracker.]

The House Energy and Commerce Committee approved the House FDA Reauthorization Act (FDARA), which includes the FDA-industry MDUFA...

More from Legislation

More from Policy & Regulation